Drugs / Shexiang Baoxin Pill
last change Sep 2025 re-read 2 minutes ago

Shexiang Baoxin Pill

also known as MUSKARDIA

Traditional medicine (herbal / TCM)

Developed for
acute myocardial infarction · coronary artery disorder
Investigated by
Shanghai Hutchison Pharmaceuticals Limited · Affiliated Hospital of Jiangsu University · Affiliated Hospital of Shandong University of Traditional Chinese Medicine · Ankang Central Hospital · Ansteel Group General Hospital · Anyang Area Hospital of Puyang City
+101 more · Beijing Chao Yang Hospital · Beijing Electric Power Hospital · Beijing Friendship Hospital · Cangzhou Central Hospital · Changzhi Medical College · Chaohu Hospital of Anhui Medical University · Civil Aviation General Hospital · Dazhou First People's Hospital · First Affiliated Hospital of Fujian Medical University · First Affiliated Hospital of Nanyang Medical College · First Affiliated Hospital of Ningbo University · First People's Hospital of Chenzhou · GUI LIN PEOPLE'S HOSPITAL · General Hospital of Fuxin Mining Industry Group of Liaoning Health Industry Group · General Hospital of Ningxia Medical University · Handan Central Hospital · Huai'an First People's Hospital · Huaibei Miners General Hospital · Huaihe Hospital of Henan University · Huang Shan People's Hospital · Huashan Hospital · Inner Mongolia Autonomous Region People's Hospital · Ji'an Central People's Hospital · Jiangxi Provincial People's Hopital · Jiaozuo Second People's Hospital · Jilin Province People's Hospital · Jingzhou Central Hospital · Jinhua Central Hospital · Jining First People's Hospital · Jun Li · Lanzhou University Second Hospital · LinFen People's Hospital · Linyi People's Hospital · Longhua Hospital · North China University of Science and Technology · Peking University People's Hospital · People's Hospital of Chongqing · People's Hospital of Quzhou · Qianfoshan Hospital · Renmin Hospital of Wuhan University · Rizhao People's Hospital · Second Affiliated Hospital of Soochow University · Second Affiliated Hospital, School of Medicine, Zhejiang University · Second Xiangya Hospital of Central South University · Shandong Provincial Hospital · Shanghai 10th People's Hospital · Shanghai 6th People's Hospital · Shanghai East Hospital · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai Zhongshan Hospital · Shanxi Cardiovascular Hospital · Shaoguan People's Hospital · Shijiazhuang People's Hospital · Shuguang Hospital of Shanghai University of Traditional Chinese Medicine · Sir Run Run Shaw Hospital · Taizhou Enze Medical Center Group · The Affiliated Hospital Of Southwest Medical University · The Affiliated Hospital of Qingdao University · The Central Hospital of Shaoyang · The First Affiliated Hospital of Anhui Medical University · The First Affiliated Hospital of Dalian Medical University · The First Affiliated Hospital of Guangdong Pharmaceutical University · The First Affiliated Hospital of Henan University of Science and Technology · The First Affiliated Hospital of Nanchang University · The First Affiliated Hospital of University of South China · The First Affiliated Hospital of Zhengzhou University · The First Affiliated Hospital with Nanjing Medical University · The First Hospital of Hebei Medical University · The First People's Hospital of Changde City · The First People's Hospital of Chu Zhou · The First People's Hospital of Lianyungang · The First People's Hospital of Nanning · The People's Hospital of JiangMen · The People's Hospital of Jizhou District, Tianjin · all 107 on the full record

Trials 2 · a red edge is where a trial was stopped

201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT07153744 Sep 2025 → Dec 2028 expected acute myocardial infarction Shanghai Hutchison Pharmaceuticals Limited Not yet recruiting No outcome recorded
Phase 4 NCT03072121 Jun 2017 → Dec 2018 coronary artery disorder Jun Li Unknown No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Shexiang Baoxin Pill ClinicalTrials.gov intervention name — accepted as the source's own label NCT07153744
1

NCT03072121

Known as MUSKARDIA “Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction” NCT07153744
Modality Traditional medicine (herbal / TCM) “Shexiang Baoxin Pill (SBP), a type of Chinese patent medicine, has been widely used to treat CAD in China for many years.” PMID 29444778 Feb 2018
Route Oral “Shexiang baoxin 22.5mg pill by mouth,2 pills three times daily for 6 months” NCT03072121